Biosyent Inc. (RX) — Long-term Investment Intensity
Biosyent Inc. (RX) has a Long-term Investment Intensity of 11.3% as of September 2025. Long-term investments of CA$5.40 Million represent 11.3% of total assets of CA$47.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check RX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biosyent Inc. Long-term Investment Intensity (2023–2024)
This chart shows how Biosyent Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of September 2025, the intensity stands at 11.3%, reflecting long-term investments of CA$5.40 Million against total assets of CA$47.79 Million CAD. Explore Biosyent Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Biosyent Inc. (2023–2024)
The table below presents the year-by-year Long-term Investment Intensity for Biosyent Inc. from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Biosyent Inc. stock valuation.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 24.4% | CA$10.10 Million | CA$41.36 Million | ▲ +18.4 pp |
| 2023 | 6.0% | CA$2.50 Million | CA$41.53 Million | — |